Structure

Physi-Chem Properties

Molecular Weight:  480.09
Volume:  430.728
LogP:  -0.027
LogD:  -0.107
LogS:  -3.942
# Rotatable Bonds:  4
TPSA:  230.74
# H-Bond Aceptor:  13
# H-Bond Donor:  9
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.208
Synthetic Accessibility Score:  4.169
Fsp3:  0.286
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  3
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.403
MDCK Permeability:  7.825270586181432e-06
Pgp-inhibitor:  0.034
Pgp-substrate:  0.194
Human Intestinal Absorption (HIA):  0.573
20% Bioavailability (F20%):  0.027
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  90.19216918945312%
Volume Distribution (VD):  0.759
Pgp-substrate:  15.691261291503906%

ADMET: Metabolism

CYP1A2-inhibitor:  0.158
CYP1A2-substrate:  0.038
CYP2C19-inhibitor:  0.014
CYP2C19-substrate:  0.042
CYP2C9-inhibitor:  0.057
CYP2C9-substrate:  0.104
CYP2D6-inhibitor:  0.014
CYP2D6-substrate:  0.132
CYP3A4-inhibitor:  0.045
CYP3A4-substrate:  0.006

ADMET: Excretion

Clearance (CL):  4.821
Half-life (T1/2):  0.932

ADMET: Toxicity

hERG Blockers:  0.229
Human Hepatotoxicity (H-HT):  0.245
Drug-inuced Liver Injury (DILI):  0.989
AMES Toxicity:  0.868
Rat Oral Acute Toxicity:  0.016
Maximum Recommended Daily Dose:  0.005
Skin Sensitization:  0.887
Carcinogencity:  0.039
Eye Corrosion:  0.003
Eye Irritation:  0.791
Respiratory Toxicity:  0.021

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC282987

Natural Product ID:  NPC282987
Common Name*:   Gossypetin-8-Glucoside
IUPAC Name:   2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Synonyms:   Gossypetin-8-Glucoside
Standard InCHIKey:  SJRXVLUZMMDCNG-KKPQBLLMSA-N
Standard InCHI:  InChI=1S/C21H20O13/c22-5-11-13(27)15(29)17(31)21(32-11)34-19-10(26)4-9(25)12-14(28)16(30)18(33-20(12)19)6-1-2-7(23)8(24)3-6/h1-4,11,13,15,17,21-27,29-31H,5H2/t11-,13-,15+,17-,21+/m1/s1
SMILES:  c1cc(c(cc1c1c(c(=O)c2c(cc(c(c2o1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL402915
PubChem CID:   5281621
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003540] Flavonoid-8-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. whole plant n.a. DOI[10.1007/BF02329610]
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. n.a. n.a. PMID[15270561]
NPO29734 Fioria vitifolia Species Malvaceae Eukaryota n.a. n.a. n.a. PMID[23738444]
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO21072 Rhododendron dauricum Species Ericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2266 Individual Protein Fructose-1,6-bisphosphatase Homo sapiens Inhibition < 20.0 % PMID[543270]
NPT1 Others Radical scavenging activity EC50 = 25.5 ug PMID[543268]
NPT2 Others Unspecified Inhibition = 99.06 % PMID[543269]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC282987 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC84265
1.0 High Similarity NPC245014
0.9938 High Similarity NPC117260
0.9938 High Similarity NPC476405
0.9876 High Similarity NPC24043
0.9876 High Similarity NPC101026
0.9876 High Similarity NPC169977
0.9876 High Similarity NPC42773
0.9876 High Similarity NPC45522
0.9876 High Similarity NPC21666
0.9874 High Similarity NPC58716
0.9874 High Similarity NPC146792
0.9874 High Similarity NPC45618
0.9815 High Similarity NPC101191
0.9815 High Similarity NPC477848
0.9815 High Similarity NPC49344
0.9815 High Similarity NPC135277
0.9815 High Similarity NPC43211
0.9815 High Similarity NPC115760
0.9815 High Similarity NPC210094
0.9815 High Similarity NPC237435
0.9812 High Similarity NPC201292
0.9812 High Similarity NPC469931
0.9812 High Similarity NPC45638
0.9812 High Similarity NPC58053
0.9812 High Similarity NPC186807
0.9812 High Similarity NPC475942
0.9812 High Similarity NPC93337
0.9812 High Similarity NPC105025
0.9812 High Similarity NPC226294
0.9811 High Similarity NPC197285
0.9811 High Similarity NPC21100
0.9755 High Similarity NPC211532
0.9755 High Similarity NPC8573
0.9755 High Similarity NPC169733
0.9755 High Similarity NPC233994
0.9755 High Similarity NPC472385
0.9755 High Similarity NPC198324
0.9748 High Similarity NPC277205
0.9695 High Similarity NPC168584
0.9693 High Similarity NPC264735
0.9691 High Similarity NPC3583
0.9691 High Similarity NPC205076
0.9691 High Similarity NPC211594
0.9691 High Similarity NPC172807
0.9691 High Similarity NPC307518
0.9691 High Similarity NPC48773
0.9691 High Similarity NPC254540
0.9691 High Similarity NPC259152
0.9689 High Similarity NPC225434
0.9689 High Similarity NPC471457
0.9689 High Similarity NPC219904
0.9689 High Similarity NPC112755
0.9689 High Similarity NPC170675
0.9689 High Similarity NPC120099
0.9689 High Similarity NPC203050
0.9689 High Similarity NPC223747
0.9688 High Similarity NPC253662
0.9688 High Similarity NPC145038
0.9688 High Similarity NPC88789
0.9688 High Similarity NPC56077
0.9688 High Similarity NPC274618
0.9688 High Similarity NPC118284
0.9688 High Similarity NPC179950
0.9688 High Similarity NPC281131
0.9688 High Similarity NPC276222
0.9688 High Similarity NPC308404
0.9686 High Similarity NPC270335
0.9686 High Similarity NPC191306
0.9636 High Similarity NPC473682
0.9636 High Similarity NPC241423
0.9636 High Similarity NPC470444
0.9636 High Similarity NPC110941
0.9636 High Similarity NPC470443
0.9636 High Similarity NPC126784
0.9636 High Similarity NPC473571
0.9634 High Similarity NPC268533
0.9634 High Similarity NPC65563
0.9634 High Similarity NPC470949
0.9632 High Similarity NPC204693
0.9632 High Similarity NPC4390
0.963 High Similarity NPC285197
0.963 High Similarity NPC22195
0.963 High Similarity NPC206123
0.963 High Similarity NPC21190
0.963 High Similarity NPC224462
0.963 High Similarity NPC34287
0.963 High Similarity NPC20505
0.963 High Similarity NPC155763
0.963 High Similarity NPC105511
0.963 High Similarity NPC471416
0.963 High Similarity NPC183357
0.963 High Similarity NPC235260
0.9627 High Similarity NPC325555
0.9627 High Similarity NPC127546
0.9627 High Similarity NPC265530
0.9627 High Similarity NPC226304
0.9627 High Similarity NPC52550
0.9627 High Similarity NPC84362
0.9627 High Similarity NPC223424
0.9627 High Similarity NPC317489
0.9627 High Similarity NPC173637
0.9625 High Similarity NPC55786
0.9625 High Similarity NPC19388
0.9625 High Similarity NPC240431
0.9625 High Similarity NPC311830
0.9625 High Similarity NPC22832
0.9623 High Similarity NPC189142
0.9623 High Similarity NPC77660
0.9578 High Similarity NPC222674
0.9578 High Similarity NPC473073
0.9578 High Similarity NPC473071
0.9573 High Similarity NPC472607
0.9571 High Similarity NPC26230
0.9571 High Similarity NPC60735
0.9571 High Similarity NPC190003
0.9571 High Similarity NPC153755
0.9571 High Similarity NPC175107
0.9568 High Similarity NPC95855
0.9568 High Similarity NPC138927
0.9568 High Similarity NPC472381
0.9568 High Similarity NPC210042
0.9568 High Similarity NPC472383
0.9565 High Similarity NPC135599
0.9565 High Similarity NPC254306
0.9565 High Similarity NPC99957
0.9565 High Similarity NPC328940
0.9565 High Similarity NPC113968
0.9565 High Similarity NPC181616
0.9565 High Similarity NPC277174
0.9565 High Similarity NPC73855
0.9563 High Similarity NPC88023
0.9563 High Similarity NPC88043
0.9563 High Similarity NPC243930
0.9563 High Similarity NPC222936
0.9563 High Similarity NPC94777
0.9563 High Similarity NPC284960
0.9563 High Similarity NPC168822
0.9563 High Similarity NPC309025
0.9563 High Similarity NPC19709
0.9521 High Similarity NPC107987
0.9521 High Similarity NPC36138
0.9521 High Similarity NPC470449
0.9521 High Similarity NPC470446
0.9521 High Similarity NPC470447
0.9521 High Similarity NPC473072
0.9521 High Similarity NPC470445
0.9515 High Similarity NPC472382
0.9515 High Similarity NPC472991
0.9515 High Similarity NPC472992
0.9515 High Similarity NPC472380
0.9515 High Similarity NPC472384
0.9512 High Similarity NPC51774
0.9512 High Similarity NPC239549
0.9512 High Similarity NPC236191
0.9509 High Similarity NPC116864
0.9509 High Similarity NPC255157
0.9509 High Similarity NPC44558
0.9509 High Similarity NPC95866
0.9509 High Similarity NPC67105
0.9509 High Similarity NPC474434
0.9509 High Similarity NPC156869
0.9509 High Similarity NPC254855
0.9509 High Similarity NPC67326
0.9509 High Similarity NPC29958
0.9509 High Similarity NPC244776
0.9509 High Similarity NPC259896
0.9509 High Similarity NPC72249
0.9509 High Similarity NPC136042
0.9506 High Similarity NPC42892
0.9506 High Similarity NPC135345
0.9506 High Similarity NPC160156
0.9506 High Similarity NPC92565
0.9506 High Similarity NPC275454
0.9506 High Similarity NPC229729
0.9506 High Similarity NPC93099
0.9506 High Similarity NPC45400
0.9503 High Similarity NPC165720
0.95 High Similarity NPC473043
0.9464 High Similarity NPC148710
0.9464 High Similarity NPC470416
0.9464 High Similarity NPC470451
0.9464 High Similarity NPC470455
0.9455 High Similarity NPC294815
0.9455 High Similarity NPC220173
0.9455 High Similarity NPC16194
0.9455 High Similarity NPC473327
0.9455 High Similarity NPC19108
0.9455 High Similarity NPC253685
0.9455 High Similarity NPC476472
0.9451 High Similarity NPC471725
0.9451 High Similarity NPC155877
0.9451 High Similarity NPC267254
0.9451 High Similarity NPC134532
0.9451 High Similarity NPC245452
0.9451 High Similarity NPC472386
0.9451 High Similarity NPC203259
0.9451 High Similarity NPC33054
0.9451 High Similarity NPC471748
0.9451 High Similarity NPC301683

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC282987 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9815 High Similarity NPD4338 Clinical (unspecified phase)
0.9451 High Similarity NPD6797 Phase 2
0.9448 High Similarity NPD7054 Approved
0.9394 High Similarity NPD7251 Discontinued
0.939 High Similarity NPD7472 Approved
0.9387 High Similarity NPD3818 Discontinued
0.9337 High Similarity NPD7808 Phase 3
0.9273 High Similarity NPD7074 Phase 3
0.913 High Similarity NPD4381 Clinical (unspecified phase)
0.9062 High Similarity NPD2801 Approved
0.903 High Similarity NPD6168 Clinical (unspecified phase)
0.903 High Similarity NPD6167 Clinical (unspecified phase)
0.903 High Similarity NPD6166 Phase 2
0.8882 High Similarity NPD1934 Approved
0.8869 High Similarity NPD7804 Clinical (unspecified phase)
0.8773 High Similarity NPD3817 Phase 2
0.8742 High Similarity NPD1512 Approved
0.872 High Similarity NPD3882 Suspended
0.8712 High Similarity NPD2393 Clinical (unspecified phase)
0.8659 High Similarity NPD5402 Approved
0.8616 High Similarity NPD1511 Approved
0.8606 High Similarity NPD4868 Clinical (unspecified phase)
0.8528 High Similarity NPD4380 Phase 2
0.8439 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8405 Intermediate Similarity NPD1653 Approved
0.8343 Intermediate Similarity NPD5494 Approved
0.8333 Intermediate Similarity NPD7075 Discontinued
0.8286 Intermediate Similarity NPD6559 Discontinued
0.8232 Intermediate Similarity NPD5403 Approved
0.8221 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8204 Intermediate Similarity NPD6801 Discontinued
0.8177 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD3751 Discontinued
0.8155 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD3787 Discontinued
0.8125 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8114 Intermediate Similarity NPD5844 Phase 1
0.811 Intermediate Similarity NPD5401 Approved
0.8075 Intermediate Similarity NPD1549 Phase 2
0.8049 Intermediate Similarity NPD6799 Approved
0.8047 Intermediate Similarity NPD1465 Phase 2
0.7978 Intermediate Similarity NPD7685 Pre-registration
0.7931 Intermediate Similarity NPD6232 Discontinued
0.7901 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD7473 Discontinued
0.7895 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD1510 Phase 2
0.7874 Intermediate Similarity NPD1247 Approved
0.7872 Intermediate Similarity NPD6778 Approved
0.7872 Intermediate Similarity NPD6779 Approved
0.7872 Intermediate Similarity NPD6781 Approved
0.7872 Intermediate Similarity NPD6776 Approved
0.7872 Intermediate Similarity NPD6782 Approved
0.7872 Intermediate Similarity NPD6780 Approved
0.7872 Intermediate Similarity NPD6777 Approved
0.7869 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD7228 Approved
0.784 Intermediate Similarity NPD2796 Approved
0.7836 Intermediate Similarity NPD7819 Suspended
0.7824 Intermediate Similarity NPD7411 Suspended
0.7818 Intermediate Similarity NPD6190 Approved
0.7798 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.779 Intermediate Similarity NPD8313 Approved
0.779 Intermediate Similarity NPD8312 Approved
0.7784 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7199 Phase 2
0.7771 Intermediate Similarity NPD6959 Discontinued
0.7765 Intermediate Similarity NPD6599 Discontinued
0.7759 Intermediate Similarity NPD6234 Discontinued
0.775 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD1613 Approved
0.7749 Intermediate Similarity NPD7435 Discontinued
0.7684 Intermediate Similarity NPD3926 Phase 2
0.7674 Intermediate Similarity NPD37 Approved
0.7657 Intermediate Similarity NPD919 Approved
0.7656 Intermediate Similarity NPD7698 Approved
0.7656 Intermediate Similarity NPD7696 Phase 3
0.7656 Intermediate Similarity NPD7697 Approved
0.7651 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD4965 Approved
0.7644 Intermediate Similarity NPD4966 Approved
0.7644 Intermediate Similarity NPD4967 Phase 2
0.764 Intermediate Similarity NPD943 Approved
0.7617 Intermediate Similarity NPD7871 Phase 2
0.7617 Intermediate Similarity NPD7870 Phase 2
0.7606 Intermediate Similarity NPD6534 Approved
0.7606 Intermediate Similarity NPD6535 Approved
0.759 Intermediate Similarity NPD7701 Phase 2
0.7576 Intermediate Similarity NPD7266 Discontinued
0.7545 Intermediate Similarity NPD3750 Approved
0.7542 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD7584 Approved
0.7531 Intermediate Similarity NPD1240 Approved
0.753 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD7874 Approved
0.7513 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3749 Approved
0.7487 Intermediate Similarity NPD7699 Phase 2
0.7487 Intermediate Similarity NPD7700 Phase 2
0.7485 Intermediate Similarity NPD1933 Approved
0.7485 Intermediate Similarity NPD230 Phase 1
0.7475 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7475 Intermediate Similarity NPD7801 Approved
0.7475 Intermediate Similarity NPD7783 Phase 2
0.7462 Intermediate Similarity NPD8151 Discontinued
0.7455 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD3027 Phase 3
0.7439 Intermediate Similarity NPD1607 Approved
0.7438 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD8455 Phase 2
0.7423 Intermediate Similarity NPD6823 Phase 2
0.741 Intermediate Similarity NPD2935 Discontinued
0.741 Intermediate Similarity NPD1551 Phase 2
0.7391 Intermediate Similarity NPD7240 Approved
0.7378 Intermediate Similarity NPD447 Suspended
0.7345 Intermediate Similarity NPD7768 Phase 2
0.7344 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD4628 Phase 3
0.7301 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7287 Intermediate Similarity NPD8150 Discontinued
0.7287 Intermediate Similarity NPD8434 Phase 2
0.7273 Intermediate Similarity NPD6844 Discontinued
0.7267 Intermediate Similarity NPD2534 Approved
0.7267 Intermediate Similarity NPD2532 Approved
0.7267 Intermediate Similarity NPD2533 Approved
0.7246 Intermediate Similarity NPD3748 Approved
0.7231 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6213 Phase 3
0.7188 Intermediate Similarity NPD6212 Phase 3
0.7184 Intermediate Similarity NPD920 Approved
0.7176 Intermediate Similarity NPD2800 Approved
0.7176 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD8319 Approved
0.7172 Intermediate Similarity NPD8320 Phase 1
0.717 Intermediate Similarity NPD1091 Approved
0.7168 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6233 Phase 2
0.7151 Intermediate Similarity NPD5953 Discontinued
0.715 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7585 Approved
0.7117 Intermediate Similarity NPD9494 Approved
0.7102 Intermediate Similarity NPD3226 Approved
0.71 Intermediate Similarity NPD7583 Approved
0.7092 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD2313 Discontinued
0.7076 Intermediate Similarity NPD6674 Discontinued
0.7074 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD4363 Phase 3
0.7062 Intermediate Similarity NPD4360 Phase 2
0.7052 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD7286 Phase 2
0.7041 Intermediate Similarity NPD7033 Discontinued
0.7035 Intermediate Similarity NPD7680 Approved
0.7006 Intermediate Similarity NPD7458 Discontinued
0.7 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD5353 Approved
0.7 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6100 Approved
0.6994 Remote Similarity NPD1203 Approved
0.6988 Remote Similarity NPD6798 Discontinued
0.6977 Remote Similarity NPD1243 Approved
0.6977 Remote Similarity NPD1652 Phase 2
0.6975 Remote Similarity NPD4379 Clinical (unspecified phase)
0.697 Remote Similarity NPD4908 Phase 1
0.697 Remote Similarity NPD6832 Phase 2
0.6959 Remote Similarity NPD2346 Discontinued
0.6959 Remote Similarity NPD2344 Approved
0.6957 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2798 Approved
0.6941 Remote Similarity NPD2799 Discontinued
0.6923 Remote Similarity NPD6651 Approved
0.6919 Remote Similarity NPD5242 Approved
0.6918 Remote Similarity NPD1548 Phase 1
0.6914 Remote Similarity NPD9269 Phase 2
0.6914 Remote Similarity NPD7390 Discontinued
0.691 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6909 Remote Similarity NPD2861 Phase 2
0.69 Remote Similarity NPD5005 Approved
0.69 Remote Similarity NPD5006 Approved
0.6895 Remote Similarity NPD7549 Discontinued
0.689 Remote Similarity NPD4111 Phase 1
0.689 Remote Similarity NPD4665 Approved
0.6886 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6865 Remote Similarity NPD5711 Approved
0.6865 Remote Similarity NPD5710 Approved
0.6864 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6355 Discontinued
0.6864 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5124 Phase 1
0.6852 Remote Similarity NPD1610 Phase 2
0.6842 Remote Similarity NPD1509 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data